Towards preventive treatment of rheumatoid arthritis
- PMID: 35871801
- DOI: 10.1016/S0140-6736(22)01327-7
Towards preventive treatment of rheumatoid arthritis
Conflict of interest statement
JR and GS are principal investigators of the Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia (ARIAA) trial, which is an investigator-initiated study supported by the Innovative Medicine Initiative (project RT Cure).
Comment on
-
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.Lancet. 2022 Jul 23;400(10348):283-294. doi: 10.1016/S0140-6736(22)01193-X. Lancet. 2022. PMID: 35871815 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
